D-0081-2019 Class I Ongoing

Recalled by Hetero Labs Limited Unit V — Jadcherla Mandal, Mahaboob Nagar

FDA drug recall D-0081-2019 was initiated by Hetero Labs Limited Unit V on Aug 15, 2018 and is designated Class I. Reason for recall: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg. The recall status is ongoing. Affected quantity: 98016 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 3, 2018
Initiation Date
Aug 15, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98016 bottles

Product description

Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30

Reason for recall

Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: MON17384, Exp 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0081-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0081-2019. Report a data issue: hello@regdatalab.com.